Neovascular Age-Related Macular Degeneration: Opportunities for Development of First-in-Class Biopharmaceuticals

Author： Schiffelers Raymond M.   >   Storm Gert  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.3, 2011-06, pp. : 171-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Therapies for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

By Emerson M. Vaughn   Lauer Andreas K.  

BioDrugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 245-257

Adis International

Access to resources Recommend Favorite

Orientation and mobility in age-related macular degeneration

By Hassan S.E.   Lovie-Kitchin J.E.   Woods R.L.   Soong G.P.-Y.  

Visual Impairment Research, Vol. 1, Iss. 3, 1999-12 ,pp. : 175-180

Informa Healthcare

Access to resources Recommend Favorite

New Pharmacologic Approaches to Therapy for Age-Related Macular Degeneration

By Eter Nicole   Krohne Tim U.   Holz Frank G.  

BioDrugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 167-179

Adis International

Access to resources Recommend Favorite

Contrast sensitivity and reading in subjects with age-related macular degeneration

By Fosse Per   Valberg Arne  

Visual Impairment Research, Vol. 3, Iss. 2, 2001-08 ,pp. : 111-124

Informa Healthcare

Access to resources Recommend Favorite

Visual Hallucinations in Patients with Age-Related Macular Degeneration (AMD)

By Lannon Simon P.   Stevenson Mike R.   White Steven T.   Logan Joanne F.   Reinhardt-Rutland Anthony H.   Jackson A. Jonathan  

Visual Impairment Research, Vol. 8, Iss. 1-2, 2006-08 ,pp. : 9-16

Informa Healthcare

Access to resources Recommend Favorite